COMMUNIQUÉS West-GlobeNewswire

Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia

12/02/2024 - 22:06

Friedreich’s ataxia is a rare, genetic, life-shortening, debilitating, and neurodegenerative disorder Treatment with SKYCLARYS improved patient function compared to placebo Biogen is leveraging its expertise and [...]

Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

12/02/2024 - 22:05

SEATTLE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has closed its underwritten [...]

G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee

12/02/2024 - 22:05

RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced that the independent Data Monitoring Committee (DMC) [...]

PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston

12/02/2024 - 22:05

SAN JOSE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, [...]

Crinetics Pharmaceuticals Announces February 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12/02/2024 - 22:05

SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified [...]

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

12/02/2024 - 22:05

Commercial demand for LungFit ® PH increasing; manufacturing of upgraded devices is ramping up to meet growing demand PMA supplement for the expansion of LungFit PH label to include cardiac surgery accepted for filing [...]

Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

12/02/2024 - 22:01

STAMFORD, Conn., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) today announced the Company will host a conference call and live audio webcast on Monday, March 4, 2024, at 4:30 p.m. EST to [...]

PetVivo Reports Third Quarter of Fiscal 2024 Financial Results

12/02/2024 - 22:00

Conference call begins at 4:00 p.m. Central time today EDINA, MN, Feb. 12, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV) , an emerging biomedical device company focused on the commercialization of [...]

Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting

12/02/2024 - 21:00

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* for its CORI ◊ [...]

MEDIA ADVISORY: Families & Advocates Announce Court Action as Ford Government Grants New Long-Term Care Licenses to Corporations with Hideous Records

12/02/2024 - 20:42

TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Far from the stronger accountability promised after horrific conditions were exposed by the military in long-term care, the Ford government has decided to reward the worst of [...]

Kno2 Designated as a Qualified Health Information Network (QHIN) Under TEFCA

12/02/2024 - 19:15

BOISE, Idaho, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Kno2 is proud to announce its designation as a Qualified Health Information Network TM (QHIN TM ) under the Trusted Exchange Framework and Common Agreement SM (TEFCA SM [...]

Caregivers Cheer First Patients at New Intermountain Primary Children’s Hospital, Miller Family Campus in Lehi, Utah

12/02/2024 - 19:04

Lehi, Utah, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The first three patients at the new Intermountain Primary Children’s Hospital, Larry H. and Gail Miller Family Campus in Lehi were welcomed with cheers and applause from [...]

OneMedNet iRWD® Draws Attention at Clinical Trials Meeting

12/02/2024 - 18:47

MINNEAPOLIS, Feb. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“iRWD”), is receiving an enthusiastic [...]

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2024

12/02/2024 - 18:00

Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024

12/02/2024 - 18:00

Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) [...]

Freeline Shareholders Approve Acquisition by Syncona

12/02/2024 - 18:00

LONDON, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (“Freeline”) and Syncona Ltd (“Syncona”) today announced that Freeline’s shareholders have approved the proposal for Bidco 1354 [...]

Novo Nordisk A/S - share repurchase programme

12/02/2024 - 17:22

Bagsværd, Denmark, 12 February 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]

Canary Completes First-in-Human Trial of Cardiac Auscultation Monitoring Sensor

12/02/2024 - 17:00

The Cardiac Auscultation monitoring device was trialed for use with heart failure patients as an adjunct to care in monitoring the effectiveness of congestive heart failure medication management The limited clinical [...]

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

12/02/2024 - 16:15

ALK ( ALKB:DC / OMX: ALK B / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions [...]